Schedule 13G ownership disclosure

ELEVATION ONCOLOGY INC

Common Stock · CUSIP: 28623U101

Event date: 2024-12-31

Filing-level shares
2,610,045
Percent of class
4.41%
  • The Vanguard Group

    Shares: 2,610,045 · Class: 4.41%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000105
Form type
SCHEDULE 13G/A
Filer
Elevation Oncology, Inc.
CIK
CIK 1783032
Filed
Jan 30, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub